Zyomyx Pockets $27M in Series E Round | GenomeWeb

NEW YORK, July 30 - Zyomyx said today it has pocketed $27 million in a Series E round of private-equity financing.

Investors included existing group Credit Suisse First Boston Private Equity and newcomers Lilly BioVentures and GE Life Science and Technology Finance.

Zyomyx said the cash will go to help ramp up and launch its human cytokine protein-profiling biochip, due in early 2003.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.